Drug
TD 4208 700 G
TD 4208 700 G: highest development phase Phase 2, developed by Viatris. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Viatris
Trials
| Drug | Phase | Indication |
|---|---|---|
| TD-4208 700 μg NCT03064113 | Phase 2 | Chronic Obstructive Pulmonary Disease, COPD |
Latest
No recent events.
Follow TD 4208 700 G on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.